Biogen Inc.

United States of America (USA)

1 June 2019 - 31 May 2020

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Biogen Inc. published between 1 June 2019 - 31 May 2020 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Count Share
18 3.65

Outputs by subject (Share)

Subject Count Share
Chemistry 5 2.24
Life Sciences 14 2.48

1 June 2019 - 31 May 2020

International vs. domestic collaboration by Share

  • 41.23% Domestic
  • 58.77% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 international collaborators by Share (190 total)

  • Biogen Inc., United States of America (USA)
  • Foreign institution
  1. GlaxoSmithKline plc. (GSK), United Kingdom (UK) (1.21)
    0.21
    1
  2. Wellcome Sanger Institute, United Kingdom (UK) (1.02)
    0.27
    0.76
  3. F. Hoffmann-La Roche AG, Switzerland (0.92)
    0.25
    0.67
  4. The University of Edinburgh, United Kingdom (UK) (0.72)
    0.12
    0.60
  5. University of Basel (UB), Switzerland (0.50)
    0.17
    0.33
  6. Neurimmune Holding AG, Switzerland (0.36)
    0.23
    0.14
  7. Pompeu Fabra University (UPF), Spain (0.33)
    0.14
    0.19
  8. Acellera, Spain (0.33)
    0.14
    0.19
  9. Institute for Molecular Medicine Finland (FIMM), Finland (0.32)
    0.06
    0.26
  10. University of Zurich (UZH), Switzerland (0.29)
    0.23
    0.06

Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.

Return to institution outputs